Bone Grafts And Substitutes Market Is Expected To Reach US$ 3,872.1 Mn By 2025 | Credence Research


Posted December 10, 2019 by johnsonpaul

The global bone grafts and substitutes market was valued at US$ 2,419.2 Mn in 2016 and is expected to reach US$ 3,872.1 Mn by 2025 expanding at a CAGR of 5.72 % from 2017 to 2025.

 
The latest market report published by Credence Research, Inc. “Bone Grafts and Substitutes Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global bone grafts and substitutes market was valued at US$ 2,419.2 Mn in 2016, and is expected to reach US$ 3,872.1 Mn by 2025 expanding at a CAGR of 5.72 % from 2017 to 2025.

Browse Full Report at https://www.credenceresearch.com/report/bone-grafts-and-substitutes-market

Market Insights

According to the findings of the United Nations, the prevalence of osteoarthritis is increasing due to aging population, osteoporosis, and obesity; it is estimated by 2050 people aged above 60 years will account for 20% of the total world population with one-third of this population suffering from osteoarthritis and osteoporosis. Conventional bone grafting has been used for decades but also is found incompetent in accelerating healing, reducing the time of weight-bearing, and significant morbidity from the harvest site. Significant technological advancement in the synthetic bone grafts such as calcium phosphate cement, coralline hydroxyapatite has accelerated bone formation as its interconnected porous structure closely resembles the porosity of human cancellous bone will propel the market penetration for bone grafts and substitutes.

At present, allografts hold the largest market share due to key drivers such as the rising prevalence of osteoporosis, sports injuries and it is a cost-effective procedure as it reduces the hospital stay. Additionally, it is a quick surgical procedure and less anesthesia time is required. Bone graft substitutes show a promising sales forecast and will be the fastest-growing market majorly due to factors such as rapid wound healing due to inherent features of bone substitutes such as negative surface charge, increased protein fusion, enhanced cell attachment and favorable natural remodeling and graft resorption.

Spinal fusion currently dominates the application segment due to factors such as the rising prevalence of low spine disc herniation, burst fractures, osteoporosis, etc. and an increasing number of patients suffering from cauda equine syndrome are preferring spinal fusion surgeries to release pressure on many spinal nerves which causes paralysis in lower extremities. Dental surgeries are anticipated to be the fastest-growing market majorly due to factors such as the rising prevalence of the periodontal disease, car accidents resulting dental trauma resulting in loss of teeth and gum causing deformation in outward cosmetic appearance and dental bone grafting is also employed to maintain bone structure after tooth extraction and improved oral health.

In the current scenario, North America dominates the regional markets and the growth is mainly attributed to the presence of key drivers such as the rising prevalence of osteoporosis and periodontal diseases in the elderly population, the existence of developed healthcare facilities and presence of major players engaged in the manufacture and sale of bone grafts and substitutes. The Asia Pacific promises a lucrative market with promising sales forecast chiefly due to factors that are anticipated to propel the market growth in the Asia Pacific is the rising prevalence of traumatic injuries due to accidents, violence, etc., flourishing e-commerce industry to promote sales and supportive regulatory environment for bone grafts and substitutes.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58802

The bone grafts and substitutes market is technologically driven and includes major players such as AlloSource, Baxter Healthcare Corporation, DePuy Synthes, Medtronic plc, NuVasive, Inc., Orthofix Holdings, Inc., Orthovita, Inc., Stryker Corporation, Smith & Nephew, Inc., and Wright Medical Group N.V.

Key Market Movements:

Rising prevalence of osteoporosis and periodontal diseases in the elderly population
Increasing demand for minimally invasive surgical procedures and surge in the orthopedic specialty clinics to propel deep market penetration
Supportive regulatory environment for bone grafts and substitutes
Increasing disposable incomes and government-aided hospitals makes it feasible to avail healthcare services in low and middle-income nations
Report Scope by Segments

By Application Type

Spinal Fusion
Long Bone
Foot and Ankle
Craniomaxillofacial
Joint Reconstruction
Dental

By Material Type

Bone Grafts Substitutes
Bone Morphogenic Proteins (BMP)
Synthetic Bone Grafts
Others
Allografts
Demineralized Bone Matrix
Others

By Geography Segment

North America (the U.S., Rest of North America)
Europe (U.K., Germany, France, Rest of Europe)
Asia Pacific (China, Japan, India, Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, Latin America)

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58802
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Chris Smith
Phone +1-800-361-8290
Business Address 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
CA 95103, United States
Country United States
Categories Business , Industry , Research
Tags bone grafts and substitutes market
Last Updated December 10, 2019